Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers

Clinical trial NCT07260708 · RECRUITING

Trial details

NCT number: NCT07260708
Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancers

Start date: 2025-12-16
Primary completion: 2028-12-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.